LaBri's Body Health XPLODE 30 capsules Exclusively distribute worldwide by LaBri's Body Health.
Reported: December 27, 2017 Initiated: July 24, 2017 #D-0122-2018
Product Description
LaBri's Body Health XPLODE 30 capsules Exclusively distribute worldwide by LaBri's Body Health.
Reason for Recall
Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.
Details
- Recalling Firm
- EZWeightLossTX LLC
- Units Affected
- 1424 bottles
- Distribution
- Nationwide
- Location
- Corpus Christi, TX
Frequently Asked Questions
What product was recalled? ▼
LaBri's Body Health XPLODE 30 capsules Exclusively distribute worldwide by LaBri's Body Health.. Recalled by EZWeightLossTX LLC. Units affected: 1424 bottles.
Why was this product recalled? ▼
Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on December 27, 2017. Severity: Critical. Recall number: D-0122-2018.
Related Recalls
FDA Drug Moderate
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…
Unichem Pharmaceuticals USA Inc. · 2026-02-11
FDA Drug Critical
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…
Green Lumber Holdings, LLC · 2026-02-11
FDA Drug Moderate
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…
Granules Pharmaceuticals Inc. · 2026-02-11
FDA Drug Critical
Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11
FDA Drug Critical
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
HANDELNINE GLOBAL LLC · 2026-02-11